According to a latest study, forehead lines can be treated with a new type of botulinum toxin. This toxin appears to be well tolerated by patients and also maintains its effect over a 13 month period. This study was conducted by the Moy-Fincher Medical Group.
Generally, low doses of Clostridium botulinum toxin type A are used for treating lines on the face. It has been stated that a new botulinum toxin type A (Reloxin), which has been used in the treatment of neurological disorders, may now be under investigation for the treatment of forehead lines.
Ronald Moy, M.D., of the Moy-Fincher Medical Group, Los Angeles, and colleagues conducted a study on about 1,200 patients. In the beginning of the treatment, the study investigators injected a specific amount of the new botulinum toxin into five specific injection sites in the forehead.
During the study period innumerable adverse events were experienced by more than half of the patients. Various follow up methods were used to keep track of the toxin’s effectiveness on the patients.
The conclusion of the study was that the new botulinum toxin type A showed benefits that did not diminish with repeat treatments. The effect of the treatment was said to have started off merely in 24 hours and at an average of three days during all cycles. The cases of adverse effects in the patients decreased over time and there didn’t seem to be any safety issues.
This study was published in the Archives of Facial Plastic Surgery, one of the journals of the JAMA/Archives.